Legenda:
epaselect epa13326088 Medical staff operate in a health facility in Bunia, Ituri, Democratic Republic of Congo, 23 October 2026. The Coalition for Epidemic Preparedness Innovations, CEPI, said the Phase 2/3 clinical trial, known as Tumaini or ‘Hope’ in Swahili, was launched in Bunia. Tumaini aims to close a gap as there is currently no approved vaccine against Bundibugyo virus which causes Ebola disease. EPA/STRINGER